CYTK
Price
$33.48
Change
+$1.34 (+4.17%)
Updated
Nov 30, 6:59 PM EST
83 days until earnings call
IKT
Price
$0.94
Change
+$0.02 (+2.17%)
Updated
Nov 30, 6:59 PM EST
Ad is loading...

CYTK vs IKT ᐉ Comparison: Which is Better to Invest?

Header iconCYTK vs IKT Comparison
Open Charts CYTK vs IKTBanner chart's image
Cytokinetics
Price$33.48
Change+$1.34 (+4.17%)
Volume$1.63M
CapitalizationN/A
Inhibikase Therapeutics
Price$0.94
Change+$0.02 (+2.17%)
Volume$8.96K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs IKT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CYTK vs. IKT commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and IKT is a StrongBuy.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (CYTK: $33.48 vs. IKT: $0.94)
Brand notoriety: CYTK and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 104% vs. IKT: 3%
Market capitalization -- CYTK: $3.12B vs. IKT: $5.5M
CYTK [@Biotechnology] is valued at $3.12B. IKT’s [@Biotechnology] market capitalization is $5.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 3 bearish.
  • IKT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than IKT.

Price Growth

CYTK (@Biotechnology) experienced а +4.92% price change this week, while IKT (@Biotechnology) price change was +1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +26.89%, and the average quarterly price growth was +20.28%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 22, 2024.

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for IKT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($3.12B) has a higher market cap than IKT($5.5M). CYTK YTD gains are higher at: -26.931 vs. IKT (-68.750). IKT has higher annual earnings (EBITDA): -19.85M vs. CYTK (-462.64M). CYTK has more cash in the bank: 539M vs. IKT (16.8M). IKT has less debt than CYTK: IKT (270K) vs CYTK (748M). CYTK has higher revenues than IKT: CYTK (7.82M) vs IKT (0).
CYTKIKTCYTK / IKT
Capitalization3.12B5.5M56,797%
EBITDA-462.64M-19.85M2,331%
Gain YTD-26.931-68.75039%
P/E RatioN/AN/A-
Revenue7.82M0-
Total Cash539M16.8M3,208%
Total Debt748M270K277,037%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIKT
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ERH9.130.09
+0.94%
Allspring Utilities and High Income Fund
DBJP62.670.42
+0.68%
Xtrackers MSCI Japan Hedged Equity ETF
DYTA25.940.06
+0.25%
SGI Dynamic Tactical ETF
PWS25.970.05
+0.21%
Pacer WealthShield ETF
HYS91.66-0.14
-0.15%
PIMCO 0-5 Year High Yield Corp Bd ETF

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and VERV have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+2.26%
VERV - IKT
33%
Poorly correlated
+0.71%
BPTH - IKT
30%
Poorly correlated
+3.70%
CYTK - IKT
25%
Poorly correlated
+4.17%
TNYA - IKT
24%
Poorly correlated
+1.08%
EVAX - IKT
23%
Poorly correlated
+2.44%
More